Search Results for "Devices"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Devices. Results 111 to 120 of 220 total matches.

Beta-Adrenergic Blockers and Breast Cancer

   
The Medical Letter on Drugs and Therapeutics • Jan 23, 2012  (Issue 1382)
The Medical Letter’s free App for the iPhone, iPad and Android through your device’s App store. BlackBerry ...
Three retrospective studies have recently reported an association between beta-blocker use and a reduction in breast cancer metastasis and recurrence. No prospective, randomized trials have been published.
Med Lett Drugs Ther. 2012 Jan 23;54(1382):6-7 |  Show IntroductionHide Introduction

Drugs for Head Lice

   
The Medical Letter on Drugs and Therapeutics • Jun 10, 2024  (Issue 1704)
device that kills lice and nits through dehydration. The device blows heated air along the scalp ...
Pediculosis capitis (head lice infestations) occur in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact. Pharmacologic treatment is recommended for persons with live lice or eggs (nits) within 1 cm of the scalp. Topical pediculicides should be tried first. Oral therapy is occasionally required for refractory infestations.
Med Lett Drugs Ther. 2024 Jun 10;66(1704):89-92   doi:10.58347/tml.2024.1704a |  Show IntroductionHide Introduction

Robotic-Assisted Laparoscopic Surgery

   
The Medical Letter on Drugs and Therapeutics • Jun 14, 2010  (Issue 1340)
the devices say one limitation is decreased tactile feedback, but with the ability of robotic arms to pivot ...
The da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA) has become available in recent years for use in laparoscopic prostatectomy, gynecological procedures, general surgery, otolaryngology and cardiothoracic procedures.
Med Lett Drugs Ther. 2010 Jun 14;52(1340):45-6 |  Show IntroductionHide Introduction

Anoro Ellipta: An Inhaled Umeclidinium/Vilanterol Combination for COPD

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 2014  (Issue 1440)
bronchodilators in a single delivery device. This is the first approved indication for umeclidinium ...
The FDA has approved an inhaled fixed-dose combination of the long-acting anticholinergic umeclidinium (ue mek" li din' ee um) and the long-acting beta2-adrenergic agonist (LABA) vilanterol (Anoro Ellipta – GSK/Theravance) for once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD). Anoro Ellipta is the first product available in the US that combines two long-acting bronchodilators in a single delivery device.
Med Lett Drugs Ther. 2014 Apr 14;56(1440):30-1 |  Show IntroductionHide Introduction

Exablate Neuro for Essential Tremor

   
The Medical Letter on Drugs and Therapeutics • Mar 27, 2017  (Issue 1517)
cannot undergo an MRI scan, such as those with implanted metallic devices. Pregnancy, advanced kidney ...
The FDA has approved use of Exablate Neuro (Insightec) for unilateral thalamotomy to treat medication-refractory essential tremor in patients ≥22 years old. Exablate Neuro uses magnetic resonance-guided focused ultrasound (MRgFUS) to create lesions in the ventral intermediate nucleus of the thalamus. MRgFUS is also approved in the US for treatment of uterine fibroids and for pain palliation of bone metastases.
Med Lett Drugs Ther. 2017 Mar 27;59(1517):52-3 |  Show IntroductionHide Introduction

In Brief: Epinephrine Auto-Injectors for Anaphylaxis (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 12, 2016  (Issue 1503)
with the EpiPen products due to differences in device design and instructions for use. One pack (two auto ...
News about recent price increases for EpiPen and EpiPen Jr (Mylan) may have patients asking about other options for emergency treatment of anaphylaxis. Adrenaclick and its generic equivalent (epinephrine injection auto-injector) are the only other epinephrine auto-injectors currently available in the US. According to Impax (the manufacturer of both the brand and generic products), Adrenaclick is no longer being manufactured; the generic product will continue to be marketed after supplies of Adrenaclick are depleted. Auvi-Q (Sanofi), an epinephrine auto-injector that was approved by the FDA in...
Med Lett Drugs Ther. 2016 Sep 12;58(1503):e120 |  Show IntroductionHide Introduction

Ziconotide (Prialt) for Chronic Pain

   
The Medical Letter on Drugs and Therapeutics • Dec 05, 2005  (Issue 1223)
blocker. It is intended for use with a programmable implanted microinfusion device, but an external ...
The FDA has approved ziconotide (Prialt - Elan) intrathecal infusion for management of severe chronic pain in patients who are intolerant of or refractory to other treatments. Ziconotide is a synthetic neuronal N-type calcium channel blocker. It is intended for use with a programmable implanted microinfusion device, but an external microinfusion device can be used temporarily.
Med Lett Drugs Ther. 2005 Dec 5;47(1223):103-4 |  Show IntroductionHide Introduction

In Brief: Femlyv – An Orally Disintegrating Hormonal Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Dec 09, 2024  (Issue 1717)
in the US for years. CHOICE OF CONTRACEPTIVES — Intrauterine devices (IUDs) and the etonogestrel implant (Nexplanon ...
Femlyv (Millicent), an orally disintegrating tablet containing ethinyl estradiol and norethindrone acetate, has been approved by the FDA for prevention of pregnancy in females with a body mass index (BMI) ≤35 kg/m2. It is the first hormonal contraceptive to become available in an orally disintegrating tablet formulation. Traditional oral and chewable tablets containing ethinyl estradiol and norethindrone acetate in a wide range of doses, including those found in Femlyv, have been available in the US for years.
Med Lett Drugs Ther. 2024 Dec 9;66(1717):200   doi:10.58347/tml.2024.1717c |  Show IntroductionHide Introduction

Two Neuraminidase Inhibitors for Treatment of Influenza

   
The Medical Letter on Drugs and Therapeutics • Oct 08, 1999  (Issue 1063)
AND COST — Zanamivir is inhaled through a Diskhaler oral inhalation device similar to those used ...
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon.
Med Lett Drugs Ther. 1999 Oct 8;41(1063):91-3 |  Show IntroductionHide Introduction

Nebulized Budesonide For Asthma in Children

   
The Medical Letter on Drugs and Therapeutics • Jan 22, 2001  (Issue 1096)
for use in children less than four years old. INHALATION DELIVERY DEVICES — Inhaled drugs for asthma ...
The FDA has approved a nebulized suspension of the corticosteroid budesonide for maintenance treatment of persistent asthma in children one to eight years old.
Med Lett Drugs Ther. 2001 Jan 22;43(1096):6-7 |  Show IntroductionHide Introduction